Remodelling of Ca2+ signalling is known to influence metabolic changes in cancer cells that in turn promote aggressive behaviour; for example, expression of MCU correlates with tumour size and metastasis in triple negative breast cancer, with evidence implicating mitochondrial Ca2+ uptake in promoting HIF-1α expression and invasiveness [237]. This evidence concerns the gene MCU and cancer.